基本信息
views: 729
Career Trajectory
Bio
John C. Burnett Jr., M.D., studies the endocrine role of the heart in cardiorenal homeostasis with a focus on the natriuretic peptides in heart failure, hypertension and myocardial infarction. The long-term goal is the engineering and clinical development of novel designer natriuretic peptides for the treatment of human cardiorenal disease, including the development of innovative natriuretic peptide-based diagnostics.
With continuous funding from the National Institutes of Health, Dr. Burnett and his team have developed three novel designer peptides currently in clinical trials targeting heart failure and resistant hypertension. From this work, seven patents have been awarded and three new biotechnology companies founded.
Research Interests
Papers共 1155 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JACC-HEART FAILUREno. 1 (2024): 114-116
PNAS NEXUSno. 6 (2024): pgae225-pgae225
MANP: A natriuretic peptide-based therapy for cardiometabolic disease (2024)
JACC-BASIC TO TRANSLATIONAL SCIENCEno. 1 (2024): 18-29
American journal of physiology. Heart and circulatory physiologyno. 3 (2023): H545-H552
CIRCULATION (2023)
biorxiv(2023)
JACC: Basic to Translational Science (2023)
Ye Zheng,Shuchong Pan,Dante Moroni, J. C. Malsawmzuali, Xiao Ma,Jeson Sangaralingham,John C. Burnett
CIRCULATION RESEARCHno. 12 (2023): E65-E65
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 1171
#Citation: 33021
H-Index: 88
G-Index: 160
Sociability: 8
Diversity: 3
Activity: 42
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn